You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
These two stocks have sky-high potential.
Lemonade (LMND -10.78%) and DermTech (DMTK) have both found themselves in tricky financial situations. The reward still might outweigh the risk for these two beaten-down stocks.
*Stock prices used were the midday prices of Sept. 1, 2022. The video was published on Sept. 4, 2022.
Connor Allen has positions in DermTech, Inc. and Lemonade, Inc. The Motley Fool has positions in and recommends DermTech, Inc. and Lemonade, Inc. The Motley Fool has a disclosure policy.
Connor Allen is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through fool.com/interninvesting, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
Related Articles
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
